Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · October 2026

Life Sciences Labor Market Report: Holland-Grand Haven, MI MSA — October 2026

Holland's shrinking labor force is pricing scientific talent beyond what its jobless rate shows.

Ottawa County's labor force fell 3.2% year-over-year even as unemployment held near 3.7%, while local Validation Engineer pay ($110,300) and CRA pay ($96,908) now outpace national medians.

Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.

Key indicators

  • Ottawa County labor force change: -3.2% YoY — Unemployment steady near 3.7% in same period
  • Validation Engineer advertised pay, metro: $110,300 — vs. $106,478 national median
  • Regulatory Affairs Specialist pay, metro: $92,715 — Down significantly; national median $103,780
  • Biopharma active recruiting rate, national: 64% — 41% expect more open roles in 2026

Key takeaways

Regulatory Affairs pay fell locally while national demand stayed firm.

Metro median advertised pay for Regulatory Affairs Specialist dropped significantly to $92,715, even as national median held near $103,780 and national reports describe regulatory talent as among the hardest life sci roles to fill. Falling local pay amid falling local labor supply is an unusual signal — worth checking whether postings reflect fewer senior searches alongside cooling demand.

Validation Engineer premium outpaces the national market.

Metro median pay of $110,300 now exceeds the national figure of $106,478, consistent with sustained biologics and manufacturing investment pulling bioprocess and automation talent out of a shrinking county labor pool. Organizations benchmarking manufacturing-support roles against national data may be underpricing this function locally.

Clinical Research Associate pay is rising faster locally than nationally.

Metro median CRA pay climbed to $96,908 against a national median of $90,065 — a reversal of the usual metro discount pattern. This tracks national intelligence identifying experienced CRAs as the binding constraint on clinical operations headcount, reinforcing that build-vs-outsource CRO decisions in this market now carry a local pay premium.

A shrinking labor force is doing more work than the unemployment rate.

Ottawa County's 3.7% jobless rate looks stable, but a 3.2% year-over-year labor force decline means fewer available workers sit behind that number. Headcount planning built on unemployment-rate optimism may understate how long specialized searches will take to fill.

Median advertised pay by role — Holland-Grand Haven, MI MSA

Life Sciences roles, October 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$88,937$117,568$150,000Stable$130,339
Clinical Research Associate *$66,560$96,908$104,011Significant increase$90,065
Lab Technician$40,423$48,045$53,291Significant increase$47,840
Regulatory Affairs Specialist *$68,604$92,715$110,788Significant decline$103,780
Clinical Data Manager *$96,750$128,800$151,550Stable$123,653
Biostatistician *$111,745$130,908$156,868Stable$131,958
Validation Engineer *$82,514$110,300$120,327Significant increase$106,478

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Ottawa County's labor force contracted 3.2% year-over-year even as unemployment held near 3.7%, a combination that signals scarcity in the region's scientific and technical talent pool. Healthcare and bioscience employers continue absorbing most available capacity, while 87% of in-demand roles in the broader region require skilled credentials — a structural constraint that predates this month's hiring activity and shows no sign of easing.

What it means

Shrinking labor force alongside stable low unemployment means Life Sci employers in Holland are competing to pull credentialed professionals away from other employers, which raises the cost and timeline of every regulatory, quality, and clinical requisition. Validation Engineer pay climbing to a $110,300 metro median, above the national figure, suggests manufacturing-adjacent technical roles are commanding a local premium that build-vs-outsource models should reflect when pricing CDMO partnerships against in-house hires. Consider reviewing whether current offer bands for quality and regulatory roles account for Ottawa County's tightening labor force alongside statewide wage trend data.

Looking ahead

Early indicator: Watch whether Regulatory Affairs pay softness locally persists into November postings or reflects a temporary dip in senior-level searches. A continued decline against rising national pay would be a meaningful divergence worth flagging to compensation committees.

Emerging pressure point: Ottawa County's labor force has now declined for multiple consecutive reporting periods. Track whether Holland Hospital and other regional health systems' active recruiting campaigns pull further from an already-shrinking pool shared with biotech and device employers.

Worth watching: Michigan's halted MI BioTalent Connect funding delays pipeline-building for manufacturing and quality roles. Monitor state budget discussions for any relaunch signal, since its absence extends the timeline for building local talent supply at a premium.

Potential inflection point: National biopharma hiring sentiment is firming, with 64% of organizations actively recruiting. If that national demand reaches Holland's CDMO and device manufacturers, expect further upward pressure on Validation Engineer and CRA pay, both already running above national medians.

Sources

  1. Michigan DTMB / Center for Data and Analytics — Ottawa County labor force declined 3.2% year-over-year with unemployment near 3.7%
  2. Regional economic development survey data — 87% of in-demand regional jobs require skilled roles
  3. Life sciences industry workforce survey, 2026 — Experienced CRAs identified as hiring bottleneck nationally
  4. Biopharma industry hiring survey, 2026 — Regulatory affairs, clinical ops, CMC among hardest pharma roles to fill in 2026
  5. Michigan Strategic Fund — MI BioTalent Connect grant program halted before 2026 launch
  6. Biopharma hiring sentiment survey, 2026 — 64% of biopharma organizations actively recruiting in 2026

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.